On April 7, 2022 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, reported that management will participate in a fireside chat at the Canaccord Genuity Horizons in Oncology Virtual Conference (Press release, Harpoon Therapeutics, APR 7, 2022, View Source [SID1234611601]). The discussion will take place on Thursday, April 14, 2022 at 2:30 p.m. ET (11:30 a.m. PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the fireside chat will be available in the Investors section of the Harpoon Therapeutics website at www.harpoontx.com with an archived replay available following the event.